Skip to main content
Home

MRI findings predict Parkinson's disease progression

MR imaging could provide insight into how Parkinson’s disease will progress years before its related symptoms become debilitating.  

  • Read more about MRI findings predict Parkinson's disease progression

New editor shares vision for ACC’s flagship journal: ‘Chasing impact, not impact factor’

2024 has been a banner year for structural heart treatments, especially those focused on the tricuspid valve. In February, for example, Edwards Lifesciences made history when its Evoque transcatheter tricuspid valve replacement (TTVR) system became the first device of its kind to gain U.S. Food and Drug Administration (FDA) approval for treating tricuspid regurgitation (TR). Two months later, Abbott’s TriClip transcatheter edge-to-edge repair (TEER) system also gained FDA approval for the treatment of TR.

Veteran cardiologist Harlan M. Krumholz, MD, has a long history in medical research as both an author and an editor. He and his team want to review manuscripts quickly and publish a wide variety of voices.

  • Read more about New editor shares vision for ACC’s flagship journal: ‘Chasing impact, not impact factor’

Industry Watcher’s Digest

mayo clinic platform

Photo by Solen Feyissa via Unsplash 

Buzzworthy developments of the past few days.

  • Read more about Industry Watcher’s Digest

Healthcare leaders worldwide counting on AI to close ‘critical gaps’ in patient care

artificial intelligence in healthcare

Photo furnished by Philips

A full 85% of 2,800 surveyed across 14 countries say they’re investing in the technology now or planning to do so within three years.

  • Read more about Healthcare leaders worldwide counting on AI to close ‘critical gaps’ in patient care

Frequent sleep disruptions may increase amyloid deposits down the road

Sleepless

Daily sleep disruptions could increase the risk of developing Alzheimer’s disease in the future, new research suggests. 

  • Read more about Frequent sleep disruptions may increase amyloid deposits down the road

Diabetes drug resolves sleep apnea in up to 52% of patients—is FDA approval in the cards?

tirzepatide injections Zepbound Eli Lilly. The U.S. Food and Drug Administration (FDA) cleared Eli Lilly and Company’s tirzepatide injections for chronic weight management in adult patients who are obese, overweight or present with at least one weight-related condition such as high blood pressure or high cholesterol. These weekly injections are being sold and distributed under the brand name Zepbound. Tirzepatide is also used in Mounjaro, FDA cleared in 2022 for improving glycemic control in adults.

Based on positive results from two different trials, Eli Lilly and Company hopes to secure a new FDA approval for tirzepatide in the months ahead.

  • Read more about Diabetes drug resolves sleep apnea in up to 52% of patients—is FDA approval in the cards?

Supplemental AI education during residency linked to key benefits

Despite this, there is still no standardized AI curriculum for emerging radiologists.

  • Read more about Supplemental AI education during residency linked to key benefits

AI-powered platform for arrhythmia detection gains FDA approval

artificial intelligence robot evaluates healthcare data. Novo Nordisk announced a new collaboration with Valo Health, a healthcare technology company focused on using artificial intelligence (AI) technology to identify new drug treatments for cardiovascular disease (CVD).

The newly approved DeepRhythm Platform from Medicalgorithmics uses advanced AI to evaluate imaging results and look for signs of cardiac arrhythmias.

  • Read more about AI-powered platform for arrhythmia detection gains FDA approval

FDA approves new pulmonary artery sensor for heart failure

Endotronix, an Illinois-based healthcare technology company, has gained U.S. Food and Drug Administration approval for its Cordella Pulmonary Artery (PA) Sensor System, which uses PA pressure-guided therapy to manage and treat heart failure patients.

The Endotronix Cordella Pulmonary Artery (PA) Sensor System, which uses PA pressure-guided therapy to manage and treat heart failure patients. 

The Cordella platform from Endotronix includes an implantable sensor that tracks the patient’s PA pressure and other helpful health data.

  • Read more about FDA approves new pulmonary artery sensor for heart failure

Murderer's fate hinges on 2 different interpretations of his brain scans

man in prison behind bars

A radiologist’s testimony could deconstruct a legal team’s argument that their defendant had a brain tumor that may have affected his behavior when he shot and killed five women in 2019. 

  • Read more about Murderer's fate hinges on 2 different interpretations of his brain scans

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …562
    • Page 563
    • Page 564
    • Page 565
    • Current page 566
    • Page 567
    • Page 568
    • Page 569
    • Page 570 …
    • Next page Next ›
    • Last page Last »
Subscribe
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme